Join us at Human Proteome Organization’s #HUPO2024! If you're attending, we would welcome the opportunity to explore the power and future of proteomics with you. We invite you to drop by our Booth 20 and poster presentations below: Empowering robust population-scale MS plasma proteomics studies with nanoparticle enrichment - P-I-0212. Presented by Lee Cantrell, PhD, Bioinformatics Scientist II. DATE: October 21 | TIME: 13:15 Advancement in nanoparticle-based proteomic analysis of whole blood obtained from various dried blood spot collection devices - P-I-0165. Presented by Maik Pruess, PhD, Senior Field Application Scientist. DATE: October 21 | TIME: 13:15 Understanding the impact of genetic variants on Alzheimer's disease with mass spectrometry proteogenomics - P-III-1031. Presented by Harendra G., PhD, Senior Director of Machine Learning. DATE: October 23 | TIME: 13:00 Here is our complete schedule: https://lnkd.in/gnEvCE3y #unbiasedproteomics #plasmaproteomics #proteomicsresearch #proteomicstechnology #alzheimersdiseaseresearch #biomarkerdiscovery #Proteograph
Seer
Biotechnology Research
Redwood City, California 10,437 followers
Empowering scientists through unbiased, deep, rapid proteomics at scale
About us
At Seer, we develop innovative solutions that act as a gateway to the proteome. Our goal is to empower the scientific community with tools to achieve exceptional scientific outcomes. We do this by removing the technological barriers that stand between breakthrough ideas and the information that can make them a reality. Over the last 15 years, the fields of genomics and transcriptomics have undergone an explosion in content and discovery, fueled by massively parallel technologies that made large-scale studies possible and tractable. Advancement in those fields have deepened our understanding of biology and ushered in new treatment mechanisms and diagnostics solutions that impact everyday human life. Similar capabilities have evaded the field of proteomics. As a result, researchers have been forced into a tradeoff: the scale of the study, or the depth of its coverage. Until now. We’re committed to eliminating the obstacles that have kept proteomics’ potential from matching the pace of advancements we’ve seen in other fields. We believe that unbiased, deep, rapid, large-scale proteomics can, and must, become accessible to the broad scientific community so that we may significantly advance our understanding of biology, health, and disease. And those studies will require solutions that allow us to accurately survey and analyze the full diversity of proteins across individuals, over time.
- Website
-
https://seer.bio/
External link for Seer
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Redwood City, California
- Type
- Public Company
- Founded
- 2017
- Specialties
- proteomics, omics, innovation, large scale studies, life sciences, multiomics, proteomics services, proteomic mass spectrometry, biomarker discovery, proteomic insights, deep, unbiased proteomics, and proteomics and genomics
Locations
-
Primary
3800 Bridge Parkway
Suite 102
Redwood City, California 94065, US
Employees at Seer
Updates
-
🎉 Today is Great Place To Work US Certification Nation Day and as we celebrate being #GPTWcertified for four years in a row, this is a shout out to our extraordinary team representing #Seer around the world. While pursuing our mission to improve human health through unbiased #proteomics, your collective dedication, passion, teamwork, and expertise is what truly makes us who we are... Thank you #TeamSeer! https://seer.bio/careers/ #greatplacetowork #CertificationNationDay2024 #trailblazingscientists #bettertogether #teamwork #proteomicsresearch
-
We look forward to joining our exceptional #proteomics community at Human Proteome Organization’s #HUPO2024 in Dresden, Germany. It has been so exciting for our team to see more and more scientists leverage the #ProteographProductSuite in their research for its: 📈 Increased protein depth and throughput for biofluid studies. 🔬 Automated workflow that compresses the dynamic range of proteins. 📊 Enriched diversity of peptides upstream of an LC-MS detector. We’d welcome the opportunity to discuss your research with you. Please visit us at Booth 20 or schedule a 1:1 here: https://lnkd.in/gRAcKp_h #proteomicsresearch #proteomicstechnology #technology #scienceandinnovation #biomarkerdiscovery #Proteograph
-
We are looking forward to joining our exceptional #proteomics community at Human Proteome Organization’s #HUPO2024 in Dresden, Germany. It has been so exciting for our team to see more and more scientists leverage the #ProteographProductSuite in their research for its: 📈 Increased protein depth and throughput for biofluid studies. 🔬 Automated workflow that compresses the dynamic range of proteins. 📊 Enriched diversity of peptides upstream of a LC-MS detector. We’d welcome the opportunity to discuss your research with you. Please visit us at Booth 20 or schedule a 1:1: https://lnkd.in/gRAcKp_h. #proteomicsresearch #proteomicstechnology #technology #scienceandinnovation #biomarkerdiscovery #Proteograph
-
Congratulations to this year’s recipients of The Royal Swedish Academy of Sciences 2024 Nobel Prize in Chemistry! This exciting recognition applauds three exceptional scientists for their breakthrough research in "computational protein design" and "protein structure prediction", using machine learning and proteomics to uncover critical links between protein structure and function. Not only does their extraordinary work deepen our understanding of #humanbiology for #drugdevelopment and scientific discovery, but it also highlights the important role of #proteomics in advancing biological knowledge and #proteinscience. This is an inspiring achievement as the Seer team continues our mission to accelerate access to proteomics around the world through #technology and #innovation. Congratulations!
BREAKING NEWS The Royal Swedish Academy of Sciences has decided to award the 2024 Nobel Prize in Chemistry with one half to David Baker “for computational protein design” and the other half jointly to Demis Hassabis and John M. Jumper “for protein structure prediction.” The Nobel Prize in Chemistry 2024 is about proteins, life’s ingenious chemical tools. David Baker has succeeded with the almost impossible feat of building entirely new kinds of proteins. Demis Hassabis and John Jumper have developed an AI model to solve a 50-year-old problem: predicting proteins’ complex structures. These discoveries hold enormous potential. The diversity of life testifies to proteins’ amazing capacity as chemical tools. They control and drive all the chemical reactions that together are the basis of life. Proteins also function as hormones, signal substances, antibodies and the building blocks of different tissues. Proteins generally consist of 20 different amino acids, which can be described as life’s building blocks. In 2003, David Baker succeeded in using these blocks to design a new protein that was unlike any other protein. Since then, his research group has produced one imaginative protein creation after another, including proteins that can be used as pharmaceuticals, vaccines, nanomaterials and tiny sensors. The second discovery concerns the prediction of protein structures. In proteins, amino acids are linked together in long strings that fold up to make a three-dimensional structure, which is decisive for the protein’s function. Since the 1970s, researchers had tried to predict protein structures from amino acid sequences, but this was notoriously difficult. However, four years ago, there was a stunning breakthrough. In 2020, Demis Hassabis and John Jumper presented an AI model called AlphaFold2. With its help, they have been able to predict the structure of virtually all the 200 million proteins that researchers have identified. Since their breakthrough, AlphaFold2 has been used by more than two million people from 190 countries. Among a myriad of scientific applications, researchers can now better understand antibiotic resistance and create images of enzymes that can decompose plastic. Life could not exist without proteins. That we can now predict protein structures and design our own proteins confers the greatest benefit to humankind. Learn more Press release: https://bit.ly/3TM8oVs Popular information: https://bit.ly/3XYHZGp Advanced information: https://bit.ly/4ewMBta
-
🎉 Exciting news! We're pleased to announce this year's recipients of our inaugural 2024 Seer Insights Grant Program. Congratulations to the following awardees whose innovative projects are pushing the boundaries of #proteomics to deepen our understanding of key biological processes and improve #humanhealth. Adegoke Elikanah Olusayo, PhD, Postdoctoral Scientist, and Nathan Basisty, PhD, NIH Distinguished Scholar, National Institute on Aging (NIA), NIH. Phyllis Billia, MD, PhD, FRCPC, Clinician-Scientist, Anthony Gramolini, PhD, Professor, and Uros Kuzmanov, PhD, Research Fellow, Ted Rogers Centre for Heart Research, University of Toronto. Richard Fahlman, PhD, Professor, University of Alberta. Jennifer Korchak, PhD Student, University of Virginia. Xiang Shu, PhD, MS, Assistant Attending, Memorial Sloan Kettering Cancer Center. Jerry Zak, DPhil, PhD, Staff Scientist, Scripps Research. Learn more about these trailblazing researchers and their studies with Seer: https://lnkd.in/eDWEqCvu #SeerInsightsGrantProgram #proteomicsresearchgrants #trailblazingscientists #scienceandinnovation #unbiasedproteomics #innovation
-
Seer reposted this
If you're attending Society for Neuroscience’s #SfN24, we’d welcome the opportunity to connect with you: 🙌 Visit our Booth #335 to discuss your research challenges and ambitions with us and learn how #proteomics and the #Proteograph are driving neurology-related biological discoveries. See who will be there from our team below! 📊 Access our brand-new Neurology Research Guide full of study data, insights, and applications. 🔬 Search for data in our Protein Discovery Catalog with 36k+ proteins and accelerate your work. If you would like to request a 1:1, please do so: https://lnkd.in/gRAcKp_h. See you in Chicago! #proteomicsresearch #proteomicstechnology #biomarkerdiscovery #neurology #ProteographProductSuite #ProteographAnalysisSuite
-
Thank you, Bruce Wilcox, Ph.D, PrognomiQ Inc, for joining Seer at #BiomarkersEU24 and sharing your innovative 'omics techniques from your #lungcancer study, with a presentation that drew over 60 conference attendees! Your insights are truly helping us all discover new approaches to advancing research and science for the benefit of #humanhealth. A big thank you also to Biomarkers by Oxford Global for hosting what was an engaging and educational conference for our team! Watch this webinar, if you would like to learn more about Dr. Wilcox's research. https://lnkd.in/gHax7D7X #proteomics #proteomicsresearch #multiomics #oncologyresearch #biomarkerdiscovery #scienceandinnovation
-
PRE-CONFERENCE DAY (OCT. 5) at Society for Neuroscience's #SfN24: Join us for our poster presentation with Seer Field Application Scientist II, Ethan Y. He will offer important insights into research led by Massachusetts General Hospital that concluded deep, unbiased #proteomics may reveal systemic factors associated with #Alzheimer’s disease and related dementias. Learn how they leveraged Seer’s #ProteographProductSuite to help uncover their findings. TIME: 3pm-4pm. POSTER: PSTR012.15. Drop by our Booth #335 while attending the event, too! https://lnkd.in/g-qeSyMh #neurology #neurologyresearch #neurologicalresearch #alzheimersdisease #dementia #scienceandinnovation
-
If you're attending Society for Neuroscience’s #SfN24, we’d welcome the opportunity to connect with you: 🙌 Visit our Booth #335 to discuss your research challenges and ambitions with us and learn how #proteomics and the #Proteograph are driving neurology-related biological discoveries. See who will be there from our team below! 📊 Access our brand-new Neurology Research Guide full of study data, insights, and applications. 🔬 Search for data in our Protein Discovery Catalog with 36k+ proteins and accelerate your work. If you would like to request a 1:1, please do so: https://lnkd.in/gRAcKp_h. See you in Chicago! #proteomicsresearch #proteomicstechnology #biomarkerdiscovery #neurology #ProteographProductSuite #ProteographAnalysisSuite